Maximilian Siska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maximilian Siska has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Eric von Lieres
IBG‐1: Biotechnology Forschungszentrum Jülich Jülich Germany
5 shared publications - Katrin Rosenthal
School of Science Constructor University Bremen Germany
4 shared publications - Ehecatl Antonio del Rio Chanona
Imperial College London, Department of Chemical Engineering, London, United Kingdom
2 shared publications - Emma Pajak
The Sargent Centre for Process Systems Engineering, Department of Chemical Engineering Imperial College London London UK
2 shared publications - Laura Marie Helleckes
The Sargent Centre for Process Systems Engineering, Department of Chemical Engineering Imperial College London London UK
2 shared publications - Stephan Lütz
Chair for Bioprocess engineering, Department of Biochemical and Chemical Engineering, TU Dortmund University, Dortmund, Germany
2 shared publications
Latest Publications
- Open Access
- 25 August 2026
- Published by Elsevier in Chemical Engineering Science
- Vol. 339
Machine learning driven quantification of local bubble dynamics across a pilot scale stirred bioreactor
- 25 August 2026
- Published by Elsevier in Chemical Engineering Science
- Vol. 339
Open AccessMachine learning driven quantification of local bubble dynamics across a pilot scale stirred bioreactor
- 20 March 2026
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 123 (4)
Front Cover Image, Volume 123, Number 4, April 2026
- 20 March 2026
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 123 (4)
Front Cover Image, Volume 123, Number 4, April 2026
- Open Access
- 10 January 2026
- Published by Springer Nature in Microbial Cell Factories
- Vol. 25 (1)
Turbid but accurate: automating lysostaphin quantification including uncertainty quantification
Conventional methods for measuring antibacterial activity, such as disk-diffusion assays, have limitations in quantitative reliability and require long incubation times making them unsuitable for high-throughput applications. To address these limitations, we automated a turbidity-based assay using readily available equipment and Bayesian data analysis, enabling accurate and precise antibacterial quantification from high-throughput experiments. In this study, we demonstrate the method applied to lysostaphin, a potent anti-staphylococcal agent and promising candidate for therapeutic applications. The turbidity assay monitors optical density changes upon lysostaphin-induced lysis of a susceptible Staphylococcus strain. We validated the use of autoclaved Staphylococcus carnosus TM300 as suitable indicator strain and optimized assay conditions for dynamic range of 0.63–10 mg L −1 lysostaphin. Our integrated approach provides a robust, scalable, and reproducible platform for quantifying active lysostaphin, paving the way for its application in high-throughput screening and process development. We believe that the approach is adaptable to other turbidity-based assays, such as those assessing endolysin activity.
- 10 January 2026
- Published by Springer Nature in Microbial Cell Factories
- Vol. 25 (1)
Open AccessTurbid but accurate: automating lysostaphin quantification including uncertainty quantification
Conventional methods for measuring antibacterial activity, such as disk-diffusion assays, have limitations in quantitative reliability and require long incubation times making them unsuitable for high-throughput applications. To address these limitations, we automated a turbidity-based assay using readily available equipment and Bayesian data analysis, enabling accurate and precise antibacterial quantification from high-throughput experiments. In this study, we demonstrate the method applied to lysostaphin, a potent anti-staphylococcal agent and promising candidate for therapeutic applications. The turbidity assay monitors optical density changes upon lysostaphin-induced lysis of a susceptible Staphylococcus strain. We validated the use of autoclaved Staphylococcus carnosus TM300 as suitable indicator strain and optimized assay conditions for dynamic range of 0.63–10 mg L −1 lysostaphin. Our integrated approach provides a robust, scalable, and reproducible platform for quantifying active lysostaphin, paving the way for its application in high-throughput screening and process development. We believe that the approach is adaptable to other turbidity-based assays, such as those assessing endolysin activity.
- Top Cited PapersOpen Access
- 8 January 2026
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 123 (4) , 805-830
A Guide to Bayesian Optimization in Bioprocess Engineering
Bayesian optimization has become widely popular across various experimental sciences due to its favorable attributes: it can handle noisy data, perform well with relatively small data sets, and provide adaptive suggestions for sequential experimentation. While still in its infancy, Bayesian optimization has recently gained traction in bioprocess engineering. However, experimentation with biological systems is highly complex and the resulting experimental uncertainty requires specific extensions to classical Bayesian optimization. Moreover, current literature often targets readers with a strong statistical background, limiting its accessibility for practitioners. In light of these developments, this review has two aims: first, to provide an intuitive and practical introduction to Bayesian optimization; and second, to outline promising application areas and open algorithmic challenges, thereby highlighting opportunities for future research in machine learning.
- 8 January 2026
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 123 (4) , 805-830
Top Cited PapersOpen AccessA Guide to Bayesian Optimization in Bioprocess Engineering
Bayesian optimization has become widely popular across various experimental sciences due to its favorable attributes: it can handle noisy data, perform well with relatively small data sets, and provide adaptive suggestions for sequential experimentation. While still in its infancy, Bayesian optimization has recently gained traction in bioprocess engineering. However, experimentation with biological systems is highly complex and the resulting experimental uncertainty requires specific extensions to classical Bayesian optimization. Moreover, current literature often targets readers with a strong statistical background, limiting its accessibility for practitioners. In light of these developments, this review has two aims: first, to provide an intuitive and practical introduction to Bayesian optimization; and second, to outline promising application areas and open algorithmic challenges, thereby highlighting opportunities for future research in machine learning.
- Open Access
- 28 September 2024
- Published by Wiley in ChemCatChem
- Vol. 17 (1)
Avoiding Replicates in Biocatalysis Experiments: Machine Learning for Enzyme Cascade Optimization
The optimization of enzyme cascades is a complex and resource‐demanding task due to the multitude of parameters and synergistic effects involved. Machine learning can support the identification of optimal reaction conditions, for example, in the case of Bayesian optimization (BO), by proposing new experiments based on Gaussian process regression (GPR) and expected improvement (EI). Here, in this research BO is used to optimize the concentrations of the reaction components of an enzyme cascade. The productivity‐cost‐ratio is chosen as the optimization objective in order to achieve the highest possible productivity, which was normalized to the costs of the materials used to prevent convergence to ever‐increasing enzyme concentrations. To reduce the experimental effort, contrary to common practice in biological experiments, replicates were not used; instead, the algorithm's proposed experiments and inherent uncertainty quantification were relied upon. This approach balances parameter space exploration and exploitation, which is critical for the efficient and effective identification of optimal reaction conditions. At the optimized reaction conditions identified in this study, the productivity‐cost ratio is doubled to 38.6 mmol L−1 h−1 €−1 compared to a reference experiment. The parameter optimization required only 52 experiments while being robust to outlying experimental results.
- 28 September 2024
- Published by Wiley in ChemCatChem
- Vol. 17 (1)
Open AccessAvoiding Replicates in Biocatalysis Experiments: Machine Learning for Enzyme Cascade Optimization
The optimization of enzyme cascades is a complex and resource‐demanding task due to the multitude of parameters and synergistic effects involved. Machine learning can support the identification of optimal reaction conditions, for example, in the case of Bayesian optimization (BO), by proposing new experiments based on Gaussian process regression (GPR) and expected improvement (EI). Here, in this research BO is used to optimize the concentrations of the reaction components of an enzyme cascade. The productivity‐cost‐ratio is chosen as the optimization objective in order to achieve the highest possible productivity, which was normalized to the costs of the materials used to prevent convergence to ever‐increasing enzyme concentrations. To reduce the experimental effort, contrary to common practice in biological experiments, replicates were not used; instead, the algorithm's proposed experiments and inherent uncertainty quantification were relied upon. This approach balances parameter space exploration and exploitation, which is critical for the efficient and effective identification of optimal reaction conditions. At the optimized reaction conditions identified in this study, the productivity‐cost ratio is doubled to 38.6 mmol L−1 h−1 €−1 compared to a reference experiment. The parameter optimization required only 52 experiments while being robust to outlying experimental results.
- Open Access
Bayesian Optimization for an ATP-Regenerating In Vitro Enzyme Cascade
Enzyme cascades are an emerging synthetic tool for the synthesis of various molecules, combining the advantages of biocatalysis and of one-pot multi-step reactions. However, the more complex the enzyme cascade is, the more difficult it is to achieve adequate productivities and product concentrations. Therefore, the whole process must be optimized to account for synergistic effects. One way to deal with this challenge involves data-driven models in combination with experimental validation. Here, Bayesian optimization was applied to an ATP-producing and -regenerating enzyme cascade consisting of polyphosphate kinases. The enzyme and co-substrate concentrations were adjusted for an ATP-dependent reaction, catalyzed by mevalonate kinase (MVK). With a total of 16 experiments, we were able to iteratively optimize the initial concentrations of the components used in the one-pot synthesis to improve the specific activity of MVK with 10.2 U mg−1. The specific activity even exceeded the results of the reference reaction with stoichiometrically added ATP amounts, with which a specific activity of 8.8 U mg−1 was reached. At the same time, the product concentrations were also improved so that complete yields were achieved.
Open AccessBayesian Optimization for an ATP-Regenerating In Vitro Enzyme Cascade
Enzyme cascades are an emerging synthetic tool for the synthesis of various molecules, combining the advantages of biocatalysis and of one-pot multi-step reactions. However, the more complex the enzyme cascade is, the more difficult it is to achieve adequate productivities and product concentrations. Therefore, the whole process must be optimized to account for synergistic effects. One way to deal with this challenge involves data-driven models in combination with experimental validation. Here, Bayesian optimization was applied to an ATP-producing and -regenerating enzyme cascade consisting of polyphosphate kinases. The enzyme and co-substrate concentrations were adjusted for an ATP-dependent reaction, catalyzed by mevalonate kinase (MVK). With a total of 16 experiments, we were able to iteratively optimize the initial concentrations of the components used in the one-pot synthesis to improve the specific activity of MVK with 10.2 U mg−1. The specific activity even exceeded the results of the reference reaction with stoichiometrically added ATP amounts, with which a specific activity of 8.8 U mg−1 was reached. At the same time, the product concentrations were also improved so that complete yields were achieved.